![Daniel Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Baker
Director/Board Member at
SHATTUCK LABS, INC.
Net worth: - $ as of 31/05/2026
Profile
Daniel G.
Baker is currently an Independent Director at Shattuck Labs, Inc. and Artiva Biotherapeutics, Inc., both starting in 2025.
Dr. Baker is also the Chief Development Officer at Cue Biopharma, Inc., starting in 2024.
Former roles include Chief Executive Officer & Director at Kira Biotech Pty Ltd., Independent Non-Executive Director at Lakefront Biotherapeutics from 2022 to 2024, and Vice President-Immunology R&D at Johnson & Johnson from 2000 to 2019.
Education includes a doctorate from the University of Pennsylvania and an undergraduate degree from Gettysburg College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Daniel Baker active positions
| Companies | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Corporate Officer/Principal | 25/11/2024 |
| ARTIVA BIOTHERAPEUTICS, INC. | Director/Board Member | 28/01/2025 |
| SHATTUCK LABS, INC. | Director/Board Member | 25/08/2025 |
Former positions of Daniel Baker
| Companies | Position | End |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Director/Board Member | 06/10/2024 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2019 |
Kira Biotech Pty Ltd.
 Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Chief Executive Officer | - |
Training of Daniel Baker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
- Stock Market
- Insiders
- Daniel Baker
